文献速递心脑血管急症

成功心肺复苏并存活的心脏骤停可诱导与生存时间相关的组织学改变,并导致猝死性心律失常综合征的误诊

Cardiac arrest with successful cardiopulmonary resuscitation and survival induce histologic changes that correlate with survival time and lead to misdiagnosis in sudden arrhythmic death syndrome.
PubMed 文献 · Resuscitation · 2022-04-09
一句话结论成功心肺复苏后存活者心脏可出现低灌注相关组织学改变,与生存时间相关,可被病理医师误判为缺血性心梗或心肌炎,从而影响猝死性心律失常综合征诊断。

该回顾性观察研究分析2017至2021年间转诊至英国国家心脏病理中心的连续猝死病例,在2,568例猝死性心脏死亡中识别出126例(4.9%)低灌注改变。镜下最常见为出血和收缩带坏死(n=50,37.7%)、心内膜下急性梗死(n=44,34.1%)、间质混合炎细胞浸润(n=31,24.9%)、愈合性肉芽组织(n=9,7.1%)和心内膜下纤维化(n=1,0.7%),这些改变与复苏后生存时间相关。在41例亚组中,病理医师将14例猝死性心律失常综合征病例的低灌注改变误判为缺血性心肌梗死(n=7;17%)、心肌炎(n=5;12.1%)或其他病变(n=2;4.8%)。作者认为,了解复苏并存活病史有助于病理评估、提高猝死性心律失常综合征诊断率并推动死者亲属基因筛查。

要点

  • 2,568例猝死性心脏死亡中126例(4.9%)存在低灌注改变,宏观最常见为左心室局灶或弥漫性心内膜下出血(13.5%)。
  • 镜下改变包括出血和收缩带坏死(n=50,37.7%)、心内膜下急性梗死(n=44,34.1%)、间质混合炎细胞浸润(n=31,24.9%)、愈合性肉芽组织(n=9,7.1%)、心内膜下纤维化(n=1,0.7%)。
  • 这些低灌注相关组织学改变与复苏后生存时间相关。
  • 41例亚组中,病理医师将14例猝死性心律失常综合征病例的低灌注改变误判为缺血性心肌梗死(n=7;17%)、心肌炎(n=5;12.1%)或其他病变(n=2;4.8%)。
  • 作者认为,了解复苏并存活病史有助于一般和专家病理评估,提高猝死性心律失常综合征诊断率,并推动死者亲属基因筛查。

适用人群与场景

  • 2017至2021年间前瞻性转诊至英国国家心脏病理中心的连续猝死病例,回顾性分析其临床信息和专家心脏病理医师检查结果。

诊断标准与关键阈值

  • 猝死性心律失常综合征(SADS)定义为心脏形态学正常的猝死性心脏死亡(SCD)。
  • 低灌注改变:在复习临床信息和专家心脏病理医师检查后识别出的显示低灌注特征的病例。

研究设计与关键结果

  • 研究类型:回顾性观察研究;样本量:2,568例猝死性心脏死亡;中心数:英国国家心脏病理中心(单中心);人群:2017至2021年连续转诊的猝死病例。
  • 2,568例猝死性心脏死亡中126例(4.9%)被识别出低灌注改变。
  • 宏观最常见发现为左心室局灶或弥漫性心内膜下出血(13.5%)。
  • 镜下发现:出血和收缩带坏死(n=50,37.7%)、心内膜下急性梗死(n=44,34.1%)、间质混合炎细胞浸润(n=31,24.9%)、愈合性肉芽组织(n=9,7.1%)、心内膜下纤维化(n=1,0.7%)。
  • 这些改变与复苏后生存时间相关。
  • 在41例亚组中,病理医师将14例猝死性心律失常综合征病例的低灌注改变误判为缺血性心肌梗死(n=7;17%)、心肌炎(n=5;12.1%)或其他病变(n=2;4.8%)。

证据类型、等级与局限

  • 证据类型:回顾性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,了解复苏并存活病史应有助于一般和专家病理评估,提高猝死性心律失常综合征诊断率,并推动死者亲属基因筛查。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Sudden arrhythmic death syndrome (SADS), defined as sudden cardiac death (SCD) with a morphologically normal heart, is an important cause of sudden death. Hypoperfusion due to cardiac arrest followed by successful cardiopulmonary resuscitation (CPR) may induce histologic changes that mimic pathologic conditions. Detailed characterisation of such features and whether they could confound SADS diagnosis are not described.

METHODS: Retrospective observational study analysing all consecutive cases of sudden death prospectively referred to a UK national cardiac pathology centre between 2017 and 2021. Cases showing hypoperfusion features were identified after review of clinical information and examination by expert cardiac pathologists.

RESULTS: Out of 2,568 SCD cases, 126 (4.9%) were identified with hypoperfusion changes. Macroscopically, the commonest finding was left ventricular focal or diffuse subendocardial haemorrhage (13.5%). Microscopically, haemorrhage and contraction band necrosis (n = 50, 37.7%), subendocardial acute infarction (n = 44, 34.1%), interstitial mixed inflammatory cell infiltrates (n = 31, 24.9%), healing granulation tissue (n = 9, 7.1%) and subendocardial fibrosis (n = 1, 0.7%) were observed. These changes correlated to duration of survival following resuscitation. In a subcohort of 41 cases, autopsy pathologists misinterpreted such changes as ischaemic myocardial infarction (n = 7; 17%), myocarditis (n = 5; 12.1%), or other pathologies (n = 2; 4.8%) in 14 SADS cases.

CONCLUSION: We provide a comprehensive characterisation of hypoperfusion-related changes in the heart following successful CPR with survival, which are time related. These features can lead to diagnostic confusion among pathologists but knowledge of history of resuscitation with survival should help with general and expert pathology assessment and improve SADS diagnostic yield, prompting genetic screening of decedents' relatives.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Coelho-Lima J, Westaby J, Sheppard MN, et al. Cardiac arrest with successful cardiopulmonary resuscitation and survival induce histologic changes that correlate with survival time and lead to misdiagnosis in sudden arrhythmic death syndrome. Resuscitation. 2022. PMID: 35405310. doi:10.1016/j.resuscitation.2022.04.002

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。